Startups
VintaBio’s development and manufacturing team has over a century of experience in the cell and gene therapy space and its members have played key roles in the development of the most advanced therapies on the market today. Located in the historic Navy Yards of Philadelphia – the epicenter of cell and gene therapy innovation – VintaBio specializes in developing and manufacturing consistent, high-quality viral vectors, a vital and currently underserved area of CGT development. The company was founded by Junwei Sun and Dr. Shangzhen Zhou, who led development of the AAV vectors behind the first two FDA-approved gene therapies, as well as the lentiviral vector for the first FDA-approved cell therapy. VintaBio has raised $64 million in venture funding, which has been used to develop a brand new 22,500 square foot facility in Philadelphia created specifically to facilitate efficient cell and gene therapy manufacturing.
Overview
Location
United States, Pennsylvania, Philadelphia
Employees
11-50
Total raised
$64M
Founded date
2020
Funding Rounds 1
| Date | Series | Amount | Investors |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see |
Mentions in press and media 3
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Apr 11, 2023 | VintaBio, aiming to meet cell and gene therapy manufacturing needs, launches with $64M raise | Another life sciences company is launching in Philadelphia: VintaBio came out of “stealth” mode Tuesday with the announcement of a $64 million investment led by Decheng Capital, and the aim of serving the growing cell and gene therapy indus... |
| VintaBio | “Medical HTML Template” |
Reviews 0
FAQ about VintaBio
When was VintaBio founded?
VintaBio was founded in 2020.
How much funding has VintaBio raised?
VintaBio has raised $64M in total across 1 funding round.
What has the press written about VintaBio?
Parsers VC has collected 3 articles mentioning VintaBio, among them “VintaBio, aiming to meet cell and gene therapy manufacturing needs, launches with $64M raise” (Apr 11, 2023) and “VintaBio”.
Is VintaBio still active?
VintaBio is probably closed: its latest activity on Parsers VC dates from Apr 11, 2023.